Management of COVID-19-positive asymptomatic and mildly symptomatic children

COVID-19 in Nursing Homes: The Problematic Management of Residents Without Positive COVID-19 RT-PCR

Strategic Management of Disease Covid-19

Introduction: Following the outbreak of Qovid-19, many studies have been published rapidly on research sites and scientific literature around the world. This study aimed to investigate the strategies of this epidemic. This study was conducted in a structured review method without statistical analysis that was conducted by searching related studies and resources in databases of Web of Science an...

Cardiac resynchronization therapy in asymptomatic and mildly symptomatic chronic systolic heart failure: a new era of systolic heart failure management?

T he incidence and prevalence of heart failure syndrome continue to increase, and it therefore remains a significant health problem in developed western countries. It is accompanied by high morbidity and mortality, and significantly affects the burden on health care system as well as the patients’ quality of life. Cardiac resynchronization therapy (CRT) with biventricular stimulation has recent...

COVID-19: A Window of Opportunity for Positive Healthcare Reforms

The current coronavirus disease 2019 (COVID-19) pandemic is testing healthcare systems like never before and all efforts are now being put into controlling the COVID-19 crisis. We witness increasing morbidity, delivery systems that sometimes are on the brink of collapse, and some shameless rent seeking. However, besides all the challenges, there are also possibilities t...

Improvement in exercise capacity in asymptomatic and mildly symptomatic adults after atrial septal defect percutaneous closure.

BACKGROUND Controversy exists as to whether secundum atrial septal defects (ASDs) in asymptomatic or mildly symptomatic New York Heart Association (NYHA) class I or II adult patients should be closed. METHODS AND RESULTS Thirty-seven patients (24 females; mean age 49.4 years, range 19 to 76) with a mean pulmonary to systemic flow ratio (Qp:Qs) of 2.1 (1.2 to 3.4) had a maximal oxygen uptake (...